Loading...
•
Mar 31, 2024
Sanara MedTech Q1 2024 Earnings Report
Sanara MedTech reported tenth consecutive record revenue quarter, with increased sales of soft tissue repair products.
Key Takeaways
Sanara MedTech Inc. announced its Q1 2024 results, achieving a record revenue quarter with $18.5 million in net revenue, a 19% increase year-over-year. However, the company reported a net loss of $1.8 million, compared to a net loss of $1.2 million in the same quarter of the previous year.
Sanara MedTech achieved its tenth consecutive record revenue quarter.
Net revenue for Q1 2024 was $18.5 million, a 19% increase compared to Q1 2023.
The company reported a net loss of $1.8 million for Q1 2024, compared to a net loss of $1.2 million for Q1 2023.
Adjusted EBITDA for Q1 2024 was $0.3 million, compared to negative Adjusted EBITDA of $0.3 million for the same period last year.
Sanara MedTech
Sanara MedTech
Sanara MedTech Revenue by Segment
Revenue by Segment
Soft Tissue Repair Revenue
CapyFin.comBone Fusion Products Revenue
CapyFin.comRevenue & Expenses
Visualization of income flow from segment revenue to net income